EDGAR Filing Documents for 0001683168-23-003090

Form 8-K - Current report:

SEC Accession No. 0001683168-23-003090

Filing Date

2023-05-10

Accepted

2023-05-10 07:30:13

Documents

Period of Report

2023-05-10

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	sonoma_8k.htm iXBRL	8-K	30318
2	INVESTOR PRESENTATION AS OF MAY 10, 2023.	sonoma_ex9901.htm	EX-99.1	85495
6	GRAPHIC	image_002.jpg	GRAPHIC	168759
7	GRAPHIC	image_004.jpg	GRAPHIC	147608
8	GRAPHIC	image_005.jpg	GRAPHIC	135726
9	GRAPHIC	image_007.jpg	GRAPHIC	133171
10	GRAPHIC	image_008.jpg	GRAPHIC	131669
11	GRAPHIC	image_009.jpg	GRAPHIC	130247
12	GRAPHIC	image_012.jpg	GRAPHIC	162868
13	GRAPHIC	image_014.jpg	GRAPHIC	128247
14	GRAPHIC	image_015.jpg	GRAPHIC	96174
15	GRAPHIC	image_016.jpg	GRAPHIC	104470
16	GRAPHIC	image_018.jpg	GRAPHIC	96633
17	GRAPHIC	image_020.jpg	GRAPHIC	77840
18	GRAPHIC	image_022.jpg	GRAPHIC	133858
19	GRAPHIC	image_025.jpg	GRAPHIC	15030
20	GRAPHIC	image_026.jpg	GRAPHIC	54483
21	GRAPHIC	image_027.jpg	GRAPHIC	58334
22	GRAPHIC	image_028.jpg	GRAPHIC	62377
23	GRAPHIC	image_029.jpg	GRAPHIC	49373
24	GRAPHIC	image_030.jpg	GRAPHIC	43305
25	GRAPHIC	image_031.jpg	GRAPHIC	35863
26	GRAPHIC	image_032.jpg	GRAPHIC	24235
27	GRAPHIC	image_033.jpg	GRAPHIC	49713
28	GRAPHIC	image_036.jpg	GRAPHIC	53435
	Complete submission text file	0001683168-23-003090.txt		3188354

Data Files

Seq	Description	Document	Type	Size
3	XBRL SCHEMA FILE	snoa-20230510.xsd	EX-101.SCH	3239
4	XBRL LABEL FILE	snoa-20230510_lab.xml	EX-101.LAB	34240
5	XBRL PRESENTATION FILE	snoa-20230510_pre.xml	EX-101.PRE	22367
30	EXTRACTED XBRL INSTANCE DOCUMENT	sonoma_8k_htm.xml	XML	3587

Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301

Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305

Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)